Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Rare Diseases × Collagenases × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Dupuytren Contracture 2 Rare Diseases 1 Connective Tissue Diseases 1 Arthritis 1

Interventions

Temozolomide 1 Plasma Exchange 1 Irinotecan 1 Infliximab 1 FANG vaccine 1 Collagenases 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00014742 2015-03-25

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 3 Completed

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡